Actuate Therapeutics Inc (ACTU)

SG&A Expense Growth

-9.58%

Quarterly · Period ending:

ACTU logo

ACTU SG&A Expense Growth

Latest reported-9.58%
ACTU Quarterly SG&A Growth (QoQ) (0.00% → -9.58%)
High-resolution chart · PNG

ACTU sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Actuate Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-9.5822%
22.7752%
-22.3514%
2.8209%
1.8697%
9.4695%
75.6442%
53.9369%
16.4128%
-5.8317%
35.7321%
-11.5229%
4.1789%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.